2026. HR-LCMS-Guided Metabolite Profiling and Multi-Target Molecular Docking of Ruellia tuberosa L. Reveals Potential Neuroprotective Leads Against Alzheimer’s Disease. International Journal of Research in Pharmaceutical Sciences and Technology. 9, 3 (Aug. 2026). DOI:https://doi.org/10.33974/v5x66n28.